1. Home
  2. ICU vs LRE Comparison

ICU vs LRE Comparison

Compare ICU & LRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICU
  • LRE
  • Stock Information
  • Founded
  • ICU 2018
  • LRE 2001
  • Country
  • ICU United States
  • LRE Japan
  • Employees
  • ICU N/A
  • LRE N/A
  • Industry
  • ICU Biotechnology: Pharmaceutical Preparations
  • LRE
  • Sector
  • ICU Health Care
  • LRE
  • Exchange
  • ICU Nasdaq
  • LRE Nasdaq
  • Market Cap
  • ICU 20.3M
  • LRE 24.0M
  • IPO Year
  • ICU N/A
  • LRE 2023
  • Fundamental
  • Price
  • ICU $0.80
  • LRE $1.60
  • Analyst Decision
  • ICU
  • LRE
  • Analyst Count
  • ICU 0
  • LRE 0
  • Target Price
  • ICU N/A
  • LRE N/A
  • AVG Volume (30 Days)
  • ICU 1.9M
  • LRE 70.5K
  • Earning Date
  • ICU 08-13-2025
  • LRE 01-01-0001
  • Dividend Yield
  • ICU N/A
  • LRE N/A
  • EPS Growth
  • ICU N/A
  • LRE N/A
  • EPS
  • ICU N/A
  • LRE N/A
  • Revenue
  • ICU $766,000.00
  • LRE $110,330,328.00
  • Revenue This Year
  • ICU $754.07
  • LRE N/A
  • Revenue Next Year
  • ICU $100.09
  • LRE N/A
  • P/E Ratio
  • ICU N/A
  • LRE N/A
  • Revenue Growth
  • ICU N/A
  • LRE 3.92
  • 52 Week Low
  • ICU $0.31
  • LRE $1.10
  • 52 Week High
  • ICU $6.65
  • LRE $2.49
  • Technical
  • Relative Strength Index (RSI)
  • ICU 53.18
  • LRE 49.41
  • Support Level
  • ICU $0.76
  • LRE $1.44
  • Resistance Level
  • ICU $0.81
  • LRE $1.57
  • Average True Range (ATR)
  • ICU 0.07
  • LRE 0.15
  • MACD
  • ICU 0.01
  • LRE -0.00
  • Stochastic Oscillator
  • ICU 53.69
  • LRE 34.21

About ICU SeaStar Medical Holding Corporation

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.

About LRE Lead Real Estate Co. Ltd

Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment building units to individual customers in Japan and Dallas, Texas. Predominantly, its revenue is generated from developing and selling single-family homes and condominiums. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.

Share on Social Networks: